Richards Group Inc. Announces 2026 Third Quarter Results: Revenue Growth of 2% Primarily on Acquisitions; Gross Margins up 7%
Key Highlights
- ➤Healthcare revenue up 6.3%, driven by consumables and low-price capital equipment
- ➤Gross margins grew 6.5% on stronger Healthcare mix
- ➤PharmaSystems acquisition contributed 1.8% to overall revenue growth
- ➤Packaging revenue fell 7.3%, reflecting continued lower demand
- ➤Bank debt refinanced to 2030; availability increased to $150M and $5M repaid
Expert Statements
John Glynn, President and Chief Executive Officer of Richards Group Inc.
“The third quarter of 2026 saw some important milestones that have significant impacts on the financial results. In Healthcare, we completed our first full year of ownership of the DermapenWorld business, driving the change in aesthetics revenue growth. We also saw a full quarter of the PharmaSystems consumer goods acquisition, which boosted the pharmacy division. Packaging saw a continuation of the lower demand trend experienced during the first half, with cosmetic packaging performing at a similar level to prior quarters.”
Toronto, Ontario--(Newsfile Corp. - October 29, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today results for the quarter ended September 30, 2026.
Third Quarter 2026 Highlights: * Revenue contributions from PharmaSystems acquisition (May 2026) drove overall increase of 1.8%. * Organic Healthcare revenue up 6.3%, representing a solid quarter with strong performance in each of our core Pharmacy and Aesthetic verticals. Growth was driven by consumables and low-price capital equipment. * Packaging revenue fell 7.3%, lower than the 14.4% experienced in the first half and continuing to reflect the macro environment. * Gross margins in the quarter grew 6.5% on stronger healthcare mix. * Refinanced bank debt to 2030, increased availability to $150M and repaid $5M. Management Comments:
Get started
Create a free account to read the full story.